1Elevan Biopharmaceuticals Announces the Development of Its Next-Generation Peptide Therapeutics Headquarters in Fishers, Indiana
The new 133,500-square-foot headquarters at 12001 Exit 5 Parkway will [...]
The new 133,500-square-foot headquarters at 12001 Exit 5 Parkway will [...]
The study finds that CHAI (Computational Histology AI) biomarkers stratify [...]
The launch marks a significant step in Seed’s evolution from [...]
Neuroethicist and psychiatrist are recognized for innovation and transformative interdisciplinary [...]
Partnership further validates Ethris’ novel technology platform based on stabilized [...]
CGuard® Prime was developed incorporating extensive user feedback and optimizes deliverability [...]
The study, titled “Augmented reality system for MRI-guided interventions: a [...]
The Phase 2a study EXIST (EXIdavnemab Synucleinopathy Trial), is a [...]
Chris Locke brings over two decades of global experience in [...]
This designation represents a key milestone toward future reimbursement and [...]